Paper published in a journal (Scientific congresses and symposiums)
Current regulatory requirements for registration of drugs to be used in osteoarthritis in Europe and need for clarification
Reginster, Jean-Yves
2015In Osteoporosis International, 26 (S1), p. 60
Peer Reviewed verified by ORBi
 

Files


Full Text
Current regulatory requirements for registration of drugs to be used in osteoarthritis in Europe and need for clarification.pdf
Publisher postprint (38.48 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
General & internal medicine
Author, co-author :
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Current regulatory requirements for registration of drugs to be used in osteoarthritis in Europe and need for clarification
Publication date :
2015
Event name :
WCO-IOF-ESCEO World Congress on Osteoporosis, osteoarthritis and Musculoskeletal Diseases
Event organizer :
International Osteoporosis Foundation ESCEO
Event place :
Milan, Italy
Event date :
Du 26 mars 2015 au 29 mars 2015
Audience :
International
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer Science & Business Media B.V., Godalming, United Kingdom
Volume :
26
Issue :
S1
Pages :
S60
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 17 March 2015

Statistics


Number of views
29 (2 by ULiège)
Number of downloads
5 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi